Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareCloud (CCLD) Research & Development (2016 - 2025)

CareCloud (CCLD) has disclosed Research & Development for 13 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 151.04% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Dec 2025, up 68.79% year-over-year, with the annual reading at $6.4 million for FY2025, 68.79% up from the prior year.
  • Research & Development for Q4 2025 was $2.5 million at CareCloud, up from $1.6 million in the prior quarter.
  • The five-year high for Research & Development was $5.9 million in Q4 2022, with the low at $488000.0 in Q3 2021.
  • Average Research & Development over 5 years is $1.6 million, with a median of $1.2 million recorded in 2022.
  • The sharpest move saw Research & Development crashed 79.61% in 2023, then soared 151.04% in 2025.
  • Over 5 years, Research & Development stood at $3.3 million in 2021, then soared by 81.82% to $5.9 million in 2022, then crashed by 79.61% to $1.2 million in 2023, then dropped by 16.49% to $1.0 million in 2024, then surged by 151.04% to $2.5 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $2.5 million, $1.6 million, and $1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.